ÇELİK, E. Et Al. 2021. Could Systemic Inflammation-Based Prognostic ScoresPredict the Clinical Outcome in Patients with Breast CancerTreated with Everolimus Plus Exemestane?. Eurasian Journal of Medical Investigation , vol.5, no.2 , 225-231.

ÇELİK, E., SAMANCI, N. S., Karadağ, M., Demirci, N. S., & DEMİRELLİ, F. H., (2021). Could Systemic Inflammation-Based Prognostic ScoresPredict the Clinical Outcome in Patients with Breast CancerTreated with Everolimus Plus Exemestane?. Eurasian Journal of Medical Investigation , vol.5, no.2, 225-231.

ÇELİK, Emir Et Al. "Could Systemic Inflammation-Based Prognostic ScoresPredict the Clinical Outcome in Patients with Breast CancerTreated with Everolimus Plus Exemestane?," Eurasian Journal of Medical Investigation , vol.5, no.2, 225-231, 2021

ÇELİK, Emir Et Al. "Could Systemic Inflammation-Based Prognostic ScoresPredict the Clinical Outcome in Patients with Breast CancerTreated with Everolimus Plus Exemestane?." Eurasian Journal of Medical Investigation , vol.5, no.2, pp.225-231, 2021

ÇELİK, E. Et Al. (2021) . "Could Systemic Inflammation-Based Prognostic ScoresPredict the Clinical Outcome in Patients with Breast CancerTreated with Everolimus Plus Exemestane?." Eurasian Journal of Medical Investigation , vol.5, no.2, pp.225-231.

@article{article, author={Emir ÇELİK Et Al. }, title={Could Systemic Inflammation-Based Prognostic ScoresPredict the Clinical Outcome in Patients with Breast CancerTreated with Everolimus Plus Exemestane?}, journal={Eurasian Journal of Medical Investigation}, year=2021, pages={225-231} }